ONE-WAYOngoing theme · still written in the latest filings
Risk of Intensifying Competition and Shortfall in Demand in the Regenerative Medicine-Related Market
Risk that market competitiveness and customer demand will fall short of expectations due to competitors entering the regenerative medicine-related market, technological innovation, the emergence of low-cost, high-quality alternative products, and insufficient scientific evidence.
Companies6How many companies write about this.
Threads7One company can carry more than one thread here.
PeriodFY2022 →Still being written about.
Directionhurts0 helps · 7 hurts · 0 flat